Company Profile

OraSure Technologies, Inc. Stock Price, News & Analysis

Ticker:
OSUR
Exchange:
NASDAQ
Sector:
MedTech
Location:
United States

Stock performance

4.00 USD (-3.61%)

Close

Last updated: August 6, 2026

275M USD

Market cap

Why the stock is moving

Following the latest company update, “OraSure Announces Second Quarter 2026 Financial Results”, OSUR closed down 3.61% at $4.00 on Aug 6, 2026. The move occurred in the trading session associated with this earnings update.

Company overview

Decentralized Diagnostics

OraSure Technologies develops point-of-need and at-home diagnostic tests intended to make testing more accessible, private and convenient.

Rapid-Test Portfolio

The company's products cover infectious diseases and other conditions across consumer, clinical, public-health and community settings. Subsidiaries including Sherlock Biosciences and BioMedomics broaden its diagnostic technologies.

Sample-Management Solutions

DNA Genotek provides collection and stabilization devices for molecular testing, research and biobanking. These products allow biological samples to be collected outside traditional laboratories and transported without complex handling.

Global Customer Base

OraSure sells to laboratories, hospitals, clinics, governments, research institutions, pharmaceutical companies and consumers, combining product sales with public-health and research demand.

Future catalysts

OraSure Technologies's catalysts are diagnostics demand, HIV and infectious-disease testing, and consumer-health execution. The company improves when recurring testing demand stays healthy.

Recent news

  1. 01

    OraSure Announces Second Quarter 2026 Financial Results

    Source: OraSure Technologies, Inc.

  2. 02
  3. 03

    OraSure Receives Emergency Use Authorization for Second Generation Ebola Test

    Source: OraSure Technologies, Inc.

  4. 04
  5. 05

    OraSure Announces First Quarter 2026 Financial Results

    Source: OraSure Technologies, Inc.

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of OraSure Technologies, Inc. (OSUR)?

OraSure Technologies, Inc. (OSUR) most recently closed at 4.00 USD, a -3.61% move versus the previous session.

What is the market cap of OraSure Technologies, Inc. (OSUR)?

OraSure Technologies, Inc. currently has a market capitalization of 275M USD on BioPharmSignal.

What does OraSure Technologies, Inc. do?

Decentralized Diagnostics OraSure Technologies develops point-of-need and at-home diagnostic tests intended to make testing more accessible, private and convenient. Rapid-Test Portfolio The company's products cover infectious diseases and other conditions across consumer, clinical, public-health and community settings. Subsidiaries including Sherlock...

On which exchange is OSUR stock listed?

OraSure Technologies, Inc. (OSUR) is associated with NASDAQ, United States, MedTech.

What is Decentralized?

Decentralized Diagnostics OraSure Technologies develops point-of-need and at-home diagnostic tests intended to make testing more accessible, private and convenient.

Which conditions is OraSure Technologies, Inc. targeting with Decentralized?

Decentralized Diagnostics OraSure Technologies develops point-of-need and at-home diagnostic tests intended to make testing more accessible, private and convenient. Rapid-Test Portfolio The company's products cover infectious diseases and other conditions across consumer, clinical, public-health and community settings. Subsidiaries including Sherlock...

How does OraSure Technologies, Inc. describe recent progress with Decentralized?

OraSure Technologies's catalysts are diagnostics demand, HIV and infectious-disease testing, and consumer-health execution. The company improves when recurring testing demand stays healthy.

What is Diagnostics?

Decentralized Diagnostics OraSure Technologies develops point-of-need and at-home diagnostic tests intended to make testing more accessible, private and convenient.